Caseware UK (AP4) 2025.0.111 2025.0.111 2025-11-30 2025-11-30 2026-05-29 false The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-11-19 false No description of principal activity 2 false true 16089081 2024-11-18 16089081 2024-11-19 2025-11-30 16089081 2023-12-01 2024-11-18 16089081 2025-11-30 16089081 c:Director2 2024-11-19 2025-11-30 16089081 d:CurrentFinancialInstruments 2025-11-30 16089081 d:CurrentFinancialInstruments d:WithinOneYear 2025-11-30 16089081 d:ShareCapital 2025-11-30 16089081 d:RetainedEarningsAccumulatedLosses 2025-11-30 16089081 c:FRS102 2024-11-19 2025-11-30 16089081 c:AuditExempt-NoAccountantsReport 2024-11-19 2025-11-30 16089081 c:FullAccounts 2024-11-19 2025-11-30 16089081 c:PrivateLimitedCompanyLtd 2024-11-19 2025-11-30 16089081 e:PoundSterling 2024-11-19 2025-11-30 iso4217:GBP xbrli:pure

Registered number: 16089081
| UNAUDITED FINANCIAL STATEMENTS
| FOR THE PERIOD ENDED 30 NOVEMBER 2025
| SYCAMORE HEALTH LIMITED
SYCAMORE HEALTH LIMITED REGISTERED NUMBER:16089081 |  |
STATEMENT OF FINANCIAL POSITION AS AT 30 NOVEMBER 2025
|  | 2025
Note |  | £
Current assets |  |  |
Stocks |  | 266 |
Debtors: amounts falling due within one year | 4 | 88 |
Cash at bank and in hand |  | 701 |
|  | 1,055 |
Creditors: amounts falling due within one year | 5 | (3,965) |
Net current (liabilities)/assets |  |  | (2,910)
Total assets less current liabilities |  |  | (2,910)
Net (liabilities)/assets |  |  | (2,910)
Capital and reserves |  |  |
Called up share capital |  |  | 2
Profit and loss account |  |  | (2,912)
|  |  | (2,910)
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf by:
R Safri
Director
Date: 29 May 2026
The notes on pages 2 to 3 form part of these financial statements. Page 1
SYCAMORE HEALTH LIMITED |  |
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 NOVEMBER 2025
1. | General information
The company is a private company limited by share capital, incorporated in England. The address of its registered office is: Newlands House 60 Chain House Lane Whitestake Preston PR4 4LG 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. The following principal accounting policies have been applied:
| 2.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Sale of goods Revenue from the sale of goods is recognised when all of the following conditions are satisfied: ∙the Company has transferred the significant risks and rewards of ownership to the buyer; ∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the transaction; and ∙the costs incurred or to be incurred in respect of the transaction can be measured reliably.
| 2.3 | Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads. At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.
| 2.4 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment. Page 2
SYCAMORE HEALTH LIMITED |  |
NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30 NOVEMBER 2025 2.Accounting policies (continued)
| 2.5 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.6 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
3. | Employees
| The average monthly number of employees, including directors, during the period was 2.
4. | Debtors
|  |  |  |  | 2025
|  |  |  |  | £
| Trade debtors | 32
| Other debtors | 56
|  | 88
5. | Creditors: Amounts falling due within one year
|  |  |  |  | 2025
|  |  |  |  | £
| Trade creditors | 305
| Other creditors | 2,310
| Accruals and deferred income | 1,350
|  | 3,965
| Included in other creditors is an amount payable to the directors' of £2,312.
Page 3